NIOX Group (LON:NIOX) Shares Down 2.3% - Time to Sell?

NIOX Group Plc (LON:NIOX - Get Free Report)'s share price fell 2.3% during trading on Wednesday . The company traded as low as GBX 59 ($0.73) and last traded at GBX 60 ($0.74). 260,541 shares traded hands during trading, a decline of 32% from the average session volume of 384,684 shares. The stock had previously closed at GBX 61.40 ($0.76).

NIOX Group Price Performance

The company has a market cap of £246.00 million, a price-to-earnings ratio of 2,900.00 and a beta of 0.92. The company's 50 day moving average price is GBX 62.71 and its 200 day moving average price is GBX 64.89. The company has a current ratio of 6.32, a quick ratio of 1.94 and a debt-to-equity ratio of 1.10.

Insider Activity at NIOX Group

In other news, insider Garry Watts sold 27,109 shares of the stock in a transaction dated Friday, October 25th. The shares were sold at an average price of GBX 80 ($0.98), for a total value of £21,687.20 ($26,685.37). Also, insider Jonathan Emms acquired 31,604 shares of the firm's stock in a transaction that occurred on Wednesday, December 18th. The shares were bought at an average cost of GBX 63 ($0.78) per share, for a total transaction of £19,910.52 ($24,499.22). 46.72% of the stock is owned by insiders.

NIOX Group Company Profile

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients.